Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Antimicrobial Therapeutics Reviews (3)

Edited by Edited by Karen Bush (Indiana University)
Antimicrobial Therapeutics Reviews (3)

Published: September 2014

Volume 1323

Learn More

This installment of Antimicrobial Therapeutics Reviews presents reviews on the risk/benefit of predicting a post-antibiotic era; the evolution of the regulatory framework for antibacterial agents; biology, epidemiology, and management of carbapenem-resistant Enterobacteriaceae; antibacterial resistance in sub-Saharan Africa; tuberculosis drug discovery and emerging targets; how multidrug resistance in typhoid fever affects treatment options; finding alternatives to antibiotics; barriers to the effective treatment of sepsis; continuing challenges in influenza; and the progress and future challenges of developing a dengue vaccine.